Creator: Help Dementia Editorial Team
Published: 2026-04-02T10:30:52

Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.

Dementia diagnosis sits at the center of this dementia and brain health question.

The checklist that primary care doctors should be using—but many aren’t—is the 2025 Alzheimer’s Association DETeCD-ADRD diagnostic evaluation framework. This structured approach includes five key components: a validated cognitive screening tool, mood and behavioral assessment, a focused neurologic examination, laboratory testing, and structural brain imaging. The framework exists precisely because primary care physicians have long been identified as “the first and best providers” for diagnosing dementia, yet most lack any systematic way to identify cognitive decline before it becomes severe. A 41-year-old patient walks into their family doctor’s office complaining that they’ve been forgetting names and appointments more often.

The doctor listens, maybe asks a question or two, and says everything seems fine—when in fact cognitive testing would have revealed measurable memory impairment that warrants further evaluation. This scenario plays out countless times across the country, contributing to a sobering statistic: only 41% of older adults with probable dementia are both diagnosed and aware of that diagnosis. The gap between what should happen and what actually happens in primary care dementia diagnosis is the focus of this article. We’ll walk through the checklist itself, explain why so many doctors sidestep it, explore the newest diagnostic tools including blood-based biomarkers, and address the populations most likely to be missed entirely. For patients and families, understanding what should be on this checklist can be a powerful advocate tool when visiting your primary care doctor.

Why Primary Care Doctors Miss Dementia: Understanding the Diagnosis Gap
The Structured Diagnostic Framework That Primary Care Should Follow
Quick Screening Tools That Actually Work in Primary Care
The Blood Biomarker Revolution in Dementia Diagnosis
Behavioral and Mood Assessment: The Overlooked Part of the Checklist
Addressing Disparities in Dementia Diagnosis
Making the Dementia Diagnostic Checklist Work in Your Practice
Conclusion

Why Primary Care Doctors Miss Dementia: Understanding the Diagnosis Gap

Nearly 59% of older adults with probable dementia are either undiagnosed or unaware of their diagnosis. That’s not because the tools don’t exist—it’s because primary care practices don’t consistently use them. Dementia diagnosis requires time, structured assessment, and follow-up imaging, none of which fit easily into the typical 15-minute office visit. Many doctors default to assuming that memory loss is a normal part of aging and tell patients not to worry, when cognitive testing would show something different. The problem is compounded by insurance requirements for imaging, the need for referral coordination, and the lack of standard protocols taught in most primary care residencies.

Certain groups are at even higher risk of being missed: individuals who are non-White, those with lower educational attainment, people with less obvious functional decline, and patients who arrive at appointments without a family member or caregiver. A companion at the visit significantly improves diagnostic accuracy because they can report changes that the patient themselves might minimize or not fully recognize. Someone might downplay memory lapses, but a spouse notices they’re losing track of bills or forgetting conversations from days earlier. When that voice isn’t in the room, the doctor has incomplete information and may underestimate cognitive decline. Additionally, dementia in people with lower educational backgrounds can be harder to detect using standard tools that rely on cultural knowledge or verbal fluency—these individuals may score lower for reasons unrelated to cognitive impairment, leading to misinterpretation.

Why Primary Care Doctors Miss Dementia: Understanding the Diagnosis Gap

The Structured Diagnostic Framework That Primary Care Should Follow

The 2025 DETeCD-ADRD (Diagnostic Evaluation of Cognitive Decline and Dementia in Adult Primary Care) guidelines spell out exactly what a comprehensive dementia evaluation in primary care should include. First is cognitive assessment using a validated, brief tool—not a doctor’s impression, but an actual scored test. Second is mood and behavioral evaluation, because depression and anxiety often mask or mimic cognitive decline. Third is a focused neurologic examination looking for signs of stroke, Parkinson’s disease, or other conditions that could explain symptoms. Fourth is tiered laboratory testing to rule out reversible causes like vitamin B12 deficiency, hypothyroidism, or infection. Fifth is structural brain imaging, typically MRI or CT, to look for brain atrophy, white matter changes, or stroke.

The challenge many practices face is that this checklist sounds comprehensive—because it is—but it requires coordination. A typical sequence involves the doctor ordering cognitive screening at one visit, scheduling lab work, arranging imaging through a separate department, and then synthesizing all that information. A patient might get stuck waiting for imaging approval or find that their insurance requires a neurology referral before authorizing an MRI. However, skipping any part of the checklist introduces risk. A doctor who does cognitive testing but not imaging might miss a treatable stroke or brain tumor. A doctor who does labs but not cognitive screening might find a low B12 level and treat only that, missing underlying dementia that will persist even after vitamin supplementation. The framework exists because dementia diagnosis is rarely simple—it requires looking at the whole picture.

Quick Screening Tools That Actually Work in Primary Care

The Mini-Cog is one of the most popular tools in primary care because it takes three minutes and performs remarkably well. It asks patients to recall three words, draw a clock face showing a specific time, and then recall the three words again. Studies show it has 82% sensitivity and 70% specificity for dementia—meaning it correctly identifies most people who have cognitive impairment while avoiding too many false alarms. A patient sits in the exam room and draws a clock; if they draw it correctly and remember the words, cognitive impairment is unlikely. If the clock is jumbled or they forget the words, the doctor knows cognitive assessment is needed. Two other tools frequently used are the Memory Impairment Screen (MIS) and the General Practitioner Assessment of Cognition (GPCOG).

The MIS uses four items and achieves 86% sensitivity and 91% specificity—it’s slightly more accurate than Mini-Cog but takes a bit longer. The GPCOG, also brief at under five minutes, offers 82% sensitivity and 70% specificity. The practical difference between these tools is minimal from a diagnostic accuracy standpoint; the choice often depends on what the practice prefers and whether a patient’s education level or language fluency might affect performance. However, none of these tools should replace full cognitive neuropsychological testing if initial screening is abnormal. Screening is the first step. If a patient scores in the impaired range on Mini-Cog or GPCOG, that’s a signal that more detailed testing is needed—either repeat cognitive assessment at follow-up visits to track change or referral to neurology for comprehensive testing.

Quick Screening Tools That Actually Work in Primary Care

The Blood Biomarker Revolution in Dementia Diagnosis

In July 2025, the Alzheimer’s Association released its first evidence-based clinical practice guideline specifically focused on incorporating blood-based biomarkers into dementia diagnosis. This represents a major shift in how dementia can be identified early. Blood tests can now detect proteins like phosphorylated tau and amyloid-beta that accumulate in the Alzheimer’s brain years before symptoms appear. These biomarkers are measurable and specific—a patient can have a blood draw in the primary care office and get results that inform diagnosis and prognosis, without waiting weeks for imaging referrals. The advantage of blood biomarkers is speed and accessibility.

A primary care office can order a simple blood test that costs far less than an MRI and provides biological confirmation of Alzheimer’s pathology. The limitation is that blood biomarkers are a complement to—not a replacement for—cognitive assessment and imaging. A patient might have biomarker evidence of Alzheimer’s pathology in the blood but score normally on cognitive screening, meaning they have brain changes without (yet) cognitive symptoms. Conversely, cognitive decline could be caused by vascular disease, Lewy body pathology, or frontotemporal dementia, conditions that won’t show Alzheimer’s biomarkers. This is why the checklist still requires structural imaging and neurologic examination; biomarkers answer one specific question but not all of them.

Behavioral and Mood Assessment: The Overlooked Part of the Checklist

Many primary care doctors focus heavily on memory loss and underestimate the role of mood and behavioral changes in dementia. Yet behavioral symptoms often appear before or alongside cognitive decline. A patient might present with depression, anxiety, irritability, or personality changes, and the doctor treats the depression with an antidepressant while missing that these behaviors are early signs of cognitive decline. The DETeCD-ADRD framework includes mood and behavioral assessment precisely for this reason—to catch dementia that presents atypically.

Here’s where careful clinical judgment matters: not every depressed patient has dementia, and treating depression is appropriate regardless. However, if a patient develops depression for the first time in their 70s without prior psychiatric history, or if depression doesn’t respond well to standard antidepressant treatment, cognitive assessment becomes more important. Some dementias, like frontotemporal dementia, present primarily with behavioral changes—a person becomes uninhibited, inappropriate, or emotionally blunted before memory loss becomes obvious. If a doctor sees behavioral changes and attributes them solely to mental illness without considering dementia, the diagnosis can be delayed by years, during which cognitive decline accelerates unchecked.

Behavioral and Mood Assessment: The Overlooked Part of the Checklist

Addressing Disparities in Dementia Diagnosis

The data is clear: dementia diagnosis is not equitable. Non-White older adults, people with lower educational attainment, and those from lower-income backgrounds are substantially more likely to remain undiagnosed. Part of this reflects broader healthcare disparities—access to specialists, insurance coverage for imaging, language barriers. But part also reflects how cognitive testing tools themselves can introduce bias. A screening test developed and validated primarily on highly educated white populations may not perform the same way in other groups. A clock-drawing test relies on visual-spatial skills and understanding of Western time representation.

A word-recall test depends on English language fluency and cultural familiarity with the words chosen. Addressing these disparities requires intentional effort from primary care providers: recognizing that cognitive screening results need interpretation in context, seeking out tools that have been validated across diverse populations, and ensuring that family members or trusted interpreters are present during cognitive assessment. It also means being especially alert to cognitive decline in patients who might minimize symptoms or who lack advocates. A patient from a cultural background that views dementia with shame or stigma may not bring up cognitive concerns spontaneously. A patient living alone without family close by may not realize that their forgetting is abnormal. These patients require active screening and assessment, not just waiting for them to report symptoms.

Making the Dementia Diagnostic Checklist Work in Your Practice

For primary care clinics serious about implementing the DETeCD-ADRD checklist, the practical approach involves building workflow changes and staff training. Many practices now have nurses or medical assistants administer cognitive screening tools like Mini-Cog at the start of the visit, allowing the doctor to review results during the appointment. Standing orders for labs and imaging, triggered by abnormal cognitive screening, reduce delays and coordination work. Templates in the electronic medical record that prompt for mood assessment, neurologic findings, and follow-up plan ensure that no part of the checklist is forgotten. A realistic implementation also acknowledges that not every patient needs the full diagnostic workup immediately.

Patients with normal cognitive screening and no behavioral concerns can be rescreened at annual visits, especially if they’re over 70 or have risk factors like hypertension or diabetes. The checklist is a framework, not a rigid protocol. However, once abnormal findings emerge—low cognitive screening score, new behavioral changes, or patient/family concern about memory—the full evaluation should proceed. This means having clear referral pathways to neurology, access to timely imaging, and a system for tracking results and follow-up. Without those infrastructure pieces, even a well-intentioned checklist sits unused.

Conclusion

The dementia diagnosis checklist that primary care should be using includes validated cognitive screening, mood and behavioral assessment, neurologic examination, laboratory testing, and structural brain imaging. These five components form the foundation of the 2025 DETeCD-ADRD guidelines and directly address the underdiagnosis problem: nearly 60% of people with probable dementia are either undiagnosed or unaware of their diagnosis. For primary care physicians, adopting this checklist means implementing brief screening tools like Mini-Cog, building workflow systems that support coordinated evaluation, and paying special attention to populations most at risk of being missed—particularly non-White patients, those without family support, and individuals from underserved communities. For patients and families, knowing what should be on this checklist is a form of self-advocacy.

If you’re concerned about cognitive decline in yourself or a family member, ask your primary care doctor whether they’ve used a formal cognitive screening tool. If they haven’t, request one. If abnormal findings emerge, ensure that the full diagnostic workup—including imaging and specialist consultation if needed—takes place. Early diagnosis, even in the absence of disease-modifying treatments, opens doors to planning, support services, and potential clinical trial enrollment. The checklist exists because dementia is common, often missed, and deserves systematic, structured attention in primary care.